Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
STRM

STRM - Streamline Health Solutions Inc Stock Price, Fair Value and News

0.49USD-0.01 (-2.00%)Market Closed

Market Summary

STRM
USD0.49-0.01
Market Closed
-2.00%

STRM Stock Price

View Fullscreen

STRM RSI Chart

STRM Valuation

Market Cap

30.4M

Price/Earnings (Trailing)

-1.64

Price/Sales (Trailing)

1.41

EV/EBITDA

-2.04

Price/Free Cashflow

-8.53

STRM Price/Sales (Trailing)

STRM Profitability

EBT Margin

-86.29%

Return on Equity

-107.12%

Return on Assets

-44.42%

Free Cashflow Yield

-11.73%

STRM Fundamentals

STRM Revenue

Revenue (TTM)

21.6M

Rev. Growth (Yr)

-18.79%

Rev. Growth (Qtr)

-19.23%

STRM Earnings

Earnings (TTM)

-18.5M

Earnings Growth (Yr)

5.58%

Earnings Growth (Qtr)

-99.93%

Breaking Down STRM Revenue

Last 7 days

-2%

Last 30 days

-3.9%

Last 90 days

36.1%

Trailing 12 Months

-61.1%

How does STRM drawdown profile look like?

STRM Financial Health

Current Ratio

0.76

Debt/Equity

0

Debt/Cashflow

-107.27

STRM Investor Care

Shares Dilution (1Y)

5.78%

Diluted EPS (TTM)

-0.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202422.6M21.6M00
202324.9M24.3M24.1M24.0M
202217.5M20.4M23.5M24.2M
202111.3M11.4M014.1M
202011.9M11.6M011.5M
201922.4M21.5M21.0M21.4M
201824.3M24.7M24.0M23.0M
201727.1M26.3M24.9M24.6M
201628.3M28.8M27.6M27.0M
201527.6M26.8M28.2M28.5M
201428.5M29.0M27.4M27.5M
201323.8M24.8M28.5M28.7M
201217.1M18.4M19.3M21.5M
201117.6M17.5M17.4M17.2M
20100000

Tracking the Latest Insider Buys and Sells of Streamline Health Solutions Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 29, 2024
reeves bryant j iii
acquired
46,500
0.31
150,000
chief financial officer
Apr 29, 2024
stilwill benjamin louis
acquired
52,700
0.31
170,000
president and ceo
Apr 29, 2024
lovvorn wendy l
acquired
46,500
0.31
150,000
chief people officer
Feb 07, 2024
etheridge matthew
acquired
68,000
0.34
200,000
-
Dec 04, 2023
reeves bryant j iii
acquired
14,000
0.28
50,000
interim cfo
Nov 01, 2023
stilwill benjamin louis
sold (taxes)
-3,900
0.43
-9,072
president & ceo
Nov 01, 2023
green wyche t iii
sold (taxes)
-2,135
0.43
-4,967
-
Oct 31, 2023
gibson thomas j.
back to issuer
-73,100
0.43
-170,000
former chief financial officer
Oct 31, 2023
gibson thomas j.
sold (taxes)
-9,901
0.43
-23,027
former chief financial officer
Jun 15, 2023
ferayorni justin john
acquired
125,000
1.45
86,207
-

1–10 of 50

Which funds bought or sold STRM recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 12, 2024
Radnor Capital Management, LLC
new
-
14,000
14,000
-%
Jul 11, 2024
SALEM INVESTMENT COUNSELORS INC
added
1,012
82,908
91,476
-%
Jul 10, 2024
CWM, LLC
unchanged
-
-
1,000
-%
May 23, 2024
Austin Wealth Management, LLC
reduced
-90.55
-466,738
29,181
0.01%
May 20, 2024
Virtu Financial LLC
sold off
-100
-7,000
-
-%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-27.62
-1,517
6,793
-%
May 15, 2024
HARBERT FUND ADVISORS, INC.
unchanged
-
265,332
2,315,620
1.59%
May 15, 2024
TOWNSQUARE CAPITAL LLC
reduced
-63.15
-33,603
23,955
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
added
294
80.00
102
-%
May 15, 2024
FIRST MANHATTAN CO. LLC.
unchanged
-
29.00
253
-%

1–10 of 45

Are Funds Buying or Selling STRM?

Are funds buying STRM calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own STRM
No. of Funds

Unveiling Streamline Health Solutions Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Sep 27, 2023
gci partners opportunity fund, lp
6.6%
3,917,082
SC 13G
Jun 22, 2023
tamarack advisers, lp
9.4%
5,514,515
SC 13D/A
Feb 03, 2023
marathon micro fund, lp
5.4%
3,097,380
SC 13G/A
Dec 01, 2022
tamarack advisers, lp
10.7%
5,128,308
SC 13D/A
Nov 01, 2022
pessin norman h
1.8%
981,284
SC 13D/A
Jul 11, 2022
marathon micro fund, lp
5.1%
2,500,000
SC 13G
Apr 14, 2022
gci partners opportunity fund, lp
6.0%
2,835,814
SC 13G
Feb 14, 2022
nantahala capital management, llc
0%
0
SC 13G/A
Aug 19, 2021
harbert discovery fund, lp
8.4%
3,966,637
SC 13D/A
Mar 23, 2021
tamarack advisers, lp
12.1%
5,036,063
SC 13D/A

Recent SEC filings of Streamline Health Solutions Inc

View All Filings
Date Filed Form Type Document
Jun 24, 2024
S-8
Employee Benefits Plan
Jun 14, 2024
8-K
Current Report
Jun 12, 2024
10-Q
Quarterly Report
Jun 11, 2024
8-K
Current Report
Jun 10, 2024
EFFECT
EFFECT
Jun 06, 2024
CORRESP
CORRESP
May 24, 2024
S-3/A
S-3/A
May 15, 2024
UPLOAD
UPLOAD
May 13, 2024
DEF 14A
DEF 14A
May 13, 2024
8-K
Current Report

Peers (Alternatives to Streamline Health Solutions Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
505.1B
379.5B
10.40% 13.38%
32.88
1.33
12.96% -25.81%
96.5B
206.0B
1.96% 20.86%
25.05
0.47
12.55% -43.95%
83.5B
66.7B
-5.51% 9.25%
15.27
1.25
9.59% -4.59%
75.4B
360.9B
-0.27% -15.61%
10.29
0.21
9.07% 78.83%
36.9B
155.5B
0.25% 6.19%
13.48
0.24
6.34% 84.42%
12.4B
14.7B
-2.11% 19.84%
15.13
0.84
7.99% 19.23%
12.1B
12.3B
-2.39% 31.81%
14.81
0.98
5.77% 58.74%
MID-CAP
8.3B
2.3B
1.45% -0.46%
29.16
3.6
5.96% 18.29%
6.4B
3.0B
4.71% -6.31%
-562.28
2.12
10.92% -104.06%
2.9B
1.5B
29.02% 51.55%
45.73
1.96
19.34% 40.15%
2.1B
3.5B
1.84% -48.70%
14.87
0.61
-27.67% -62.40%
SMALL-CAP
2.0B
1.1B
5.45% 34.11%
30.61
1.85
11.45% 30.74%
1.5B
3.0B
14.37% 109.32%
-8.47
0.48
4.98% 4.88%
77.1M
-
27.39% -4.87%
-5.11
-
- -1.05%
20.3M
21.6M
1.27% 26.48%
39.87
0.94
9.04% -57.88%

Streamline Health Solutions Inc News

Latest updates
Yahoo Finance20 hours ago
American Banking and Market News14 Jul 202401:59 pm
American Banking and Market News14 Jul 202401:59 pm

Streamline Health Solutions Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q22021Q12020Q42020Q22020Q12020Q12019Q42019Q32019Q22019Q1
Revenue-19.2%4,330,0005,361,0006,133,0005,770,0005,332,0006,745,0006,217,0005,992,0005,935,0006,046,0005,514,0002,951,0002,974,0002,641,0002,844,0003,825,3334,806,6675,788,0004,793,0005,357,0005,464,000
Costs and Expenses1.7%6,580,0006,467,00019,080,0008,368,0008,328,0008,581,0009,379,0008,648,0009,112,0008,153,0009,334,0005,406,0004,282,0004,515,0004,350,000-5,364,0005,325,0004,328,0004,037,0008,453,000
  S&GA Expenses21.1%3,192,0002,635,5004,122,0004,107,0003,841,0003,723,5004,055,0003,934,0004,501,0003,425,0003,439,0002,551,0001,706,5002,283,0002,291,000-2,021,0002,762,0002,402,0002,421,0002,393,000
  R&D Expenses-20.3%1,111,0001,394,0001,304,0001,305,0001,701,0001,515,0001,754,0001,461,0001,312,0001,502,0001,339,000977,000987,000753,000684,000-940,000501,000660,000589,000-611,500
EBITDA Margin-1.6%-0.60-0.59-0.59-0.23-0.26-0.25-0.06-0.17-0.10-0.16-0.57-0.60-0.52--------
Interest Expenses60.3%465,000290,000266,000267,000248,000230,000198,000189,000132,000129,00085,00013,00012,00012,00014,000-70,00091,00070,00078,00052,000
Income Taxes-100.0%-13,000-120,0008,00053,00049,0009,0002,00011,000100,0004,0009,000276,000-803,000-561,000--497,500-454,000-356,000-325,0005,500
Earnings Before Taxes-101.8%-2,739,000-1,357,000-12,031,000-2,507,000-2,848,000-2,133,000-3,129,000-3,270,000-2,776,00095,500-4,375,000-2,453,000-1,314,000-1,872,000-1,538,000--3,082,500-1,977,000-2,012,000-642,000-3,102,000
EBT Margin-4.0%-0.86-0.83-0.81-0.44-0.47-0.45-0.38-0.44-0.35-0.39-0.58-0.61-0.53--------
Net Income-99.9%-2,739,000-1,370,000-11,911,000-2,515,000-2,901,000-2,182,000-3,138,000-3,272,000-2,787,000-30,000-4,310,000-2,142,000-1,187,000-1,055,0003,673,000--2,404,000-164,000-608,000313,000-3,097,000
Net Income Margin-3.7%-0.86-0.83-0.81-0.45-0.47-0.46-0.38-0.44-0.35-0.37-0.55-0.480.03--------
Free Cashflow-1865.6%-1,199,000-61,000-1,225,000-1,080,00097,000-2,422,000-1,770,000-1,704,000-1,293,000115,000-2,500,000-480,000188,000--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
Assets0.0%42.0042.0041.0053.0056.0062.0062.0057.0060.0062.0062.0038.0040.0026.0025.0028.0029.0032.0031.0032.0032.00
  Current Assets9.8%10.009.008.009.0012.0016.0017.0011.0014.0015.0015.0020.0022.007.005.008.009.007.005.007.008.00
    Cash Equivalents24.7%4.003.003.004.006.007.0012.006.008.0010.0010.0016.0017.002.003.006.007.002.001.001.002.00
  Net PPE-13.6%0.000.000.00--0.00----0.000.000.000.000.000.000.000.000.000.000.00
  Goodwill0%13.0013.0013.0023.0023.0023.0023.0023.0023.0023.0023.0011.0011.0011.0011.0011.0011.0011.0016.0016.0016.00
Liabilities6.5%24.0023.0021.0022.0023.0026.0028.0028.0029.0028.0029.007.009.008.007.009.009.0016.0013.0017.0017.00
  Current Liabilities-6.3%13.0014.0013.0013.0014.0017.0019.0015.0015.0014.007.007.009.007.006.008.007.0016.0013.0013.0012.00
  Long Term Debt----------0.000.000.000.000.000.000.000.00----
    LT Debt, Current-100.0%-2.00-1.001.001.001.001.000.000.000.00-2.002.001.001.001.004.003.001.001.00
Shareholder's Equity-8.0%17.0019.0020.0031.0033.0036.0034.0029.0031.0034.0034.0031.0031.0017.0018.0019.0020.0016.0018.006.007.00
  Retained Earnings-2.4%-118-115-114-102-99.90-97.04-94.86-91.72-85.66-85.66-85.63-81.32-81.26-79.12-77.93-76.87-75.74-79.41-77.01-76.84-76.24
  Additional Paid-In Capital0.9%13513413313313213212812011911911911211196.0096.0096.0095.0095.0095.0083.0083.00
Accumulated Depreciation4.5%0.000.000.000.000.000.00---0.000.000.000.000.00---0.002.002.002.00
Shares Outstanding-1.2%58.0059.0059.0059.0056.0058.0048.0047.0047.0048.0046.0039.0037.0032.00-------
Float----57.00-------48.00---26.00---23.00-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
Cashflow From Operations-2120.4%-1,199-54.00-1,225-1,062126-2,422-1,770-1,681-1,270138-2,485-1,059-478190-1,712-68.00-1,903-417-2,217-1,591-1,484
  Share Based Compensation-29.2%49970560.00537572468555331326557537557565374442349263215290160269
Cashflow From Investing-1833.3%-232-12.00-536-640-433-490-564-362-519-549-12,711469-378-291-409-64510,805-662-601-761-828
Cashflow From Financing217.6%2,220699231-198-304-2,1898,1156.00-141-87.009,788-16614,614-576-610-36.00-1,72191.001,912840-152
  Buy Backs-67.00---179----------------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

STRM Income Statement

2024-04-30
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Revenues:  
Total revenues$ 4,330,000$ 5,332,000
Operating expenses:  
Selling, general and administrative expense3,192,0003,841,000
Research and development1,111,0001,701,000
Total operating expenses6,580,0008,328,000
Operating loss(2,250,000)(2,996,000)
Other (expense) income:  
Interest expense(465,000)(248,000)
Valuation adjustments(24,000)364,000
Other032,000
Loss before income taxes(2,739,000)(2,848,000)
Income tax expense0(53,000)
Net loss$ (2,739,000)$ (2,901,000)
Basic and Diluted Earnings Per Share:  
Net loss per common share – basic and diluted (in dollars per share)$ (0.05)$ (0.05)
Weighted average number of common shares – basic and diluted (in shares)[1],[2]58,224,09055,970,880
Software as a Service [Member]  
Revenues:  
Total revenues$ 2,723,000$ 3,175,000
Operating expenses:  
Cost of goods and services1,348,0001,589,000
Maintenance [Member]  
Revenues:  
Total revenues890,0001,157,000
Operating expenses:  
Cost of goods and services42,00089,000
Professional Fees and Licenses [Member]  
Revenues:  
Total revenues717,0001,000,000
Operating expenses:  
Cost of goods and services$ 887,000$ 1,108,000
[1]Diluted net loss per share excludes the effect of shares that are anti-dilutive. For the three months ended April 30, 2024, diluted earnings per share excludes 66,000 outstanding stock options, 2,687,471 unvested restricted shares of common stock, and 4,016,025 shares of common stock issuable through the exercise of warrants. For the three months ended April 30, 2023, diluted earnings per share excludes 628,958 outstanding stock options and 2,655,831 unvested restricted shares of common stock.
[2]Includes the effect of vested and excludes the effect of unvested restricted shares of common stock, which are considered non-participating securities. As of April 30, 2024 and 2023, there were 2,687,471 and 2,655,831 unvested restricted shares of common stock outstanding, respectively.

STRM Balance Sheet

2024-04-30
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Apr. 30, 2024
Jan. 31, 2024
Current assets:  
Cash and cash equivalents$ 3,979,000$ 3,190,000
Accounts receivable, net of allowance for credit losses of $117,000 and $86,000, respectively4,706,0004,237,000
Contract receivables294,000780,000
Prepaid and other current assets722,000629,000
Total current assets9,701,0008,836,000
Non-current assets:  
Property and equipment, net of accumulated amortization of $304,000 and $291,000 respectively76,00088,000
Capitalized software development costs, net of accumulated amortization of $8,396,000 and $7,960,000, respectively5,624,0005,798,000
Intangible assets, net of accumulated amortization of $4,428,000 and $4,019,000, respectively11,662,00012,071,000
Goodwill13,276,00013,276,000
Other1,386,0001,666,000
Total non-current assets32,024,00032,899,000
Total assets41,725,00041,735,000
Current liabilities:  
Accounts payable1,120,0001,253,000
Accrued expenses1,777,0002,023,000
Current portion of term loan1,750,0001,500,000
Deferred revenues7,351,0007,112,000
Acquisition earnout liability817,0001,794,000
Total current liabilities12,815,00013,682,000
Non-current liabilities:  
Term loan, net of current portion and deferred financing costs7,089,0007,566,000
Line of credit01,500,000
Non-current portion of notes payable3,587,0000
Warrants – common stock746,0000
Deferred revenues, less current portion185,000173,000
Total non-current liabilities11,607,0009,239,000
Total liabilities24,422,00022,921,000
Stockholders’ equity:  
Common stock, $0.01 par value per share, 85,000,000 shares authorized; 61,825,587 and 58,945,498 shares issued and outstanding, respectively617,000590,000
Additional paid in capital135,124,000133,923,000
Accumulated deficit(118,438,000)(115,699,000)
Total stockholders’ equity17,303,00018,814,000
Total liabilities and stockholders’ equity$ 41,725,000$ 41,735,000
STRM
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
 CEO
 WEBSITEstreamlinehealth.net
 INDUSTRYHealthcare Plans
 EMPLOYEES112

Streamline Health Solutions Inc Frequently Asked Questions


What is the ticker symbol for Streamline Health Solutions Inc? What does STRM stand for in stocks?

STRM is the stock ticker symbol of Streamline Health Solutions Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Streamline Health Solutions Inc (STRM)?

As of Tue Jul 16 2024, market cap of Streamline Health Solutions Inc is 30.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STRM stock?

You can check STRM's fair value in chart for subscribers.

What is the fair value of STRM stock?

You can check STRM's fair value in chart for subscribers. The fair value of Streamline Health Solutions Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Streamline Health Solutions Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STRM so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Streamline Health Solutions Inc a good stock to buy?

The fair value guage provides a quick view whether STRM is over valued or under valued. Whether Streamline Health Solutions Inc is cheap or expensive depends on the assumptions which impact Streamline Health Solutions Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STRM.

What is Streamline Health Solutions Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jul 16 2024, STRM's PE ratio (Price to Earnings) is -1.64 and Price to Sales (PS) ratio is 1.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STRM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Streamline Health Solutions Inc's stock?

In the past 10 years, Streamline Health Solutions Inc has provided -0.213 (multiply by 100 for percentage) rate of return.